Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Stelara Approval Expands; Good News in Celiac Disease; Curcumin for Adenomas

(MedPage Today) -- The FDA said it expanded approval of the interleukin (IL)-12/23 antagonist ustekinumab (Stelara) to include treatment of moderately to severely active ulcerative colitis in children as young as 2 years. Using pooled data from...

Stelara Approval Expands; Good News in Celiac Disease; Curcumin for Adenomas

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Thursday 3 September →